Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Rilimogene galvacirepvec [USAN]
RN: 1225283-43-1


  • NCI: A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA. (NCI Thesaurus)

Molecular Formula

  • Unspecified

Classification Code

  • Treatment of Prostate Cancer
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Rilimogene galvacirepvec [USAN]


  • Prostvac-V
  • Recombinant vaccinia virus expressing prostate specific antigen (PSA)
  • Rilimogene galvacirepvec

Systematic Name

  • Recombinant vaccinia virus expressing prostate specific antigen (PSA)

Registry Numbers

CAS Registry Number

  • 1225283-43-1

System Generated Number

  • 1225283431